A detailed history of Profund Advisors LLC transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Profund Advisors LLC holds 20,083 shares of PTGX stock, worth $815,369. This represents 0.03% of its overall portfolio holdings.

Number of Shares
20,083
Previous 14,529 38.23%
Holding current value
$815,369
Previous $503,000 79.32%
% of portfolio
0.03%
Previous 0.02%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$33.72 - $47.33 $187,280 - $262,870
5,554 Added 38.23%
20,083 $902,000
Q2 2024

Aug 13, 2024

SELL
$24.66 - $34.8 $565,848 - $798,520
-22,946 Reduced 61.23%
14,529 $503,000
Q1 2024

May 08, 2024

BUY
$21.79 - $32.15 $208,857 - $308,157
9,585 Added 34.37%
37,475 $1.08 Million
Q4 2023

Feb 14, 2024

SELL
$14.05 - $23.44 $433,105 - $722,561
-30,826 Reduced 52.5%
27,890 $639,000
Q3 2023

Nov 13, 2023

BUY
$16.68 - $23.66 $115,642 - $164,034
6,933 Added 13.39%
58,716 $979,000
Q2 2023

Aug 10, 2023

BUY
$18.02 - $29.36 $414,153 - $674,780
22,983 Added 79.8%
51,783 $1.43 Million
Q1 2023

May 11, 2023

BUY
$10.78 - $25.38 $310,464 - $730,944
28,800 New
28,800 $662,000

Others Institutions Holding PTGX

About Protagonist Therapeutics, Inc


  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $1.99B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.